Back
Bright Minds Biosciences Stock Price Chart

Top investors are buying this "unlisted" stock
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Buy
52
DRUG
Bright Minds Biosciences
Last Price:
$32.00
Seasonality Move:
-1.03%
7 Day Trial
ALL ACCESS PASS
$
7

Former Zillow execs target $1.3T market
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
The current trend is relatively stagnant and DRUG is experiencing buying pressure, which is a positive indicator for future bullish movement.
Bright Minds Biosciences Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 31.6 | Buy |
20-day SMA: | 31.97 | Buy |
50-day SMA: | 33.09 | Sell |
200-day SMA: | 27.59 | Buy |
8-day EMA: | 31.93 | Buy |
20-day EMA: | 31.95 | Buy |
50-day EMA: | 32.98 | Sell |
200-day EMA: | 27.83 | Buy |
Bright Minds Biosciences Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.27 | Sell |
Relative Strength Index (14 RSI): | 50.24 | Buy |
Chaikin Money Flow: | 8644 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (30.35 - 33.17) | Buy |
Bollinger Bands (100): | (31.32 - 39.1) | Sell |
Bright Minds Biosciences Technical Analysis
May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
02 | 05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Bright Minds Biosciences Stock
Is Bright Minds Biosciences Stock a Buy?
-
Bright Minds Biosciences share price is 32.22 while DRUG 8-day simple moving average is 31.60, which is a Buy signal.
-
The stock price of DRUG is 32.22 while Bright Minds Biosciences 20-day SMA is 31.97, which makes it a Buy.
-
Bright Minds Biosciences 50-day simple moving average is 33.09 while DRUG share price is 32.22, making it a Sell technically.
-
DRUG stock price is 32.22 and Bright Minds Biosciences 200-day simple moving average is 27.59, creating a Buy signal.
DRUG Technical Analysis vs Fundamental Analysis
Buy
52
Bright Minds Biosciences (DRUG)
is a Buy
Is Bright Minds Biosciences a Buy or a Sell?
-
Bright Minds Biosciences stock is rated a BuyThe current Bright Minds Biosciences [DRUG] share price is $32.22. The Score for DRUG is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
Bright Minds Biosciences Stock Info
Market Cap:
227M
Price in USD:
32.22
Share Volume:
15.9K
Bright Minds Biosciences 52-Week Range
52-Week High:
79.02
52-Week Low:
0.93
Buy
52
Bright Minds Biosciences (DRUG)
is a Buy
Bright Minds Biosciences Share Price Forecast
-
What is the Bright Minds Biosciences stock price today?The Bright Minds Biosciences stock price is 32.22 USD today.
-
Will DRUG stock go up or go down?Bright Minds Biosciences> share price is forecast to RISE/FALL based on technical indicators
-
Is Bright Minds Biosciences overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Bright Minds Biosciences is not overvalued.
Is Bright Minds Biosciences Stock a Buy?
-
Bright Minds Biosciences share price is 32.22 while DRUG 8-day exponential moving average is 31.93, which is a Buy signal.
-
The stock price of DRUG is 32.22 while Bright Minds Biosciences 20-day EMA is 31.95, which makes it a Buy.
-
Bright Minds Biosciences 50-day exponential moving average is 32.98 while DRUG share price is 32.22, making it a Sell technically.
-
DRUG stock price is 32.22 and Bright Minds Biosciences 200-day simple moving average is 27.83, creating a Buy signal.
Fundamental Analysis of Bright Minds Biosciences
Is Bright Minds Biosciences a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.24 per share, a decrease next quarter of $0.11 per share, a decrease this year of $0.61 per share, and a decrease next year of $1.70 per share.
Technical Analysis of Bright Minds Biosciences
Should I short Bright Minds Biosciences stock?
-
DRUG Moving Average Covergence Divergence (MACD) indicator is -0.27, suggesting Bright Minds Biosciences is a Sell
-
Bright Minds Biosciences Relative Strength Index (RSI) is 50.24, which suggest Bright Minds Biosciences is overbought
-
The Bollinger Bands (25) for Bright Minds Biosciences is (30.35 - 33.17), which suggest Bright Minds Biosciences is a Sell
-
The Bollinger Bands (100) for Bright Minds Biosciences is (31.32 - 39.1), which suggest Bright Minds Biosciences is a Sell
* Bright Minds Biosciences stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.